3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
43
INDUSTRY
41
NIH
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Wilms Tumor
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Pleuropulmonary blastoma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Breast Neoplasms
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
39
Docetaxel
30
Tamoxifen
29
Paclitaxel
27
Doxorubicin
26
Trastuzumab
20
Radiotherapy
18
Epirubicin
16
Letrozole
13
exemestane
11
Fluorouracil
11
Anastrozole
11
Capecitabine
10
Bevacizumab
10
Immunohistochemistry
9
Filgrastim
9
Fulvestrant
8
Methotrexate
7
Gene Expression Profiling
7
palbociclib
6
Zoledronic Acid
6
Microarray Analysis
6
Lapatinib
6
Goserelin
6
Chemotherapy, Adjuvant
6
Amplified Fragment Length Polymorphism Analysis
6
Vinorelbine
5
Triptorelin Pamoate
5
Carboplatin
5
Absorptiometry, Photon
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Breast Neoplasms
×
Ado-Trastuzumab Emtansine
×
Clear all
NCT04042051
2025-07-22
Panthera
Cancer Trials Ireland
Phase 1
Terminated
2 enrolled